In ₹ Crore except Per Share Latest Annual | MSTCLTD FY26 | NESCO FY26 | MEDPLUS FY26 | MANYAVAR FY25 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | 23.65× | ◆ 18.61× | 35.94× | 35.88× | 35.88× -34% | |
| P/B | 5.72× | ◆ 2.56× | 4.01× | — | 3.28× +74% | |
| EV/EBITDA | 21.23× | 14.90× | ◆ 12.69× | — | 13.80× +54% | |
| Market Cap | ₹5,167 Cr | ₹7,679 Cr | ₹7,909 Cr | — | ₹7,794 Cr -34% | |
| Growth | ||||||
| Revenue CAGR 3Y | -19.96% | ◆ 19.51% | 14.78% | 10.03% | 14.78% -235% | |
| Revenue CAGR 5Y | -13.88% | ◆ 26.21% | 17.56% | — | 21.88% -163% | |
| Net Income CAGR 3Y | -3.35% | 12.40% | ◆ 63.65% | 7.25% | 12.40% -127% | |
| Revenue YoY (latest Q) | 21.72% | 9.55% | 21.84% | ◆ 22.74% | 21.84% -1% | |
| Net Income YoY (latest Q) | ◆ 37.50% | 3.97% | -21.67% | 37.31% | 3.97% +845% | |
| Profitability | ||||||
| EBITDA Margin | ◆ 60.63% | 52.61% | 8.81% | 46.35% | 46.35% +31% | |
| Net Income Margin | ◆ 59.09% | 44.28% | 3.19% | 28.02% | 28.02% +111% | |
| Return on Common Equity | ◆ 24.16% | 13.77% | 11.12% | 21.75% | 13.77% +75% | |
| Return on Capital Employed | ◆ 22.87% | 12.65% | 10.01% | 20.87% | 12.65% +81% | |
| Return on Assets | 10.86% | 11.19% | 5.58% | ◆ 14.14% | 11.19% -3% | |
| Credit & Quality | ||||||
| Total Debt/Equity | 0.16× | ◆ 0.00× | 0.00× | — | 0.00× | |
| Interest Coverage | — | ◆ 17.49× | 2.69× | 8.87× | 8.87× | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹370 Cr | ₹932 Cr | ₹6,892 Cr | ₹1,386 Cr | ₹1,386 Cr -73% | |
| Net Income | ₹218 Cr | ₹413 Cr | ₹220 Cr | ₹388 Cr | ₹388 Cr -44% | |
| Total Assets | ₹2,011 Cr | ₹3,689 Cr | ₹3,933 Cr | ₹2,747 Cr | ₹3,689 Cr -45% | |
| EPS | ₹31.03 | ₹58.58 | ₹18.33 | ₹15.99 | ₹18.33 +69% | |
| Book Value per Share | ₹128.4 | ₹425.33 | ₹164.48 | — | ₹294.91 -56% | |